We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 4,781 results
  1. Phytogalactolipids activate humoral immunity against colorectal cancer

    Background

    Colorectal cancer (CRC) is the third most lethal cancer in the world, and its incidence is steadily rising. In this study, we investigated...

    Han-Huei Lin, Yi-Shin Wu, ... Yu-Ling Lin in Journal of Experimental & Clinical Cancer Research
    Article Open access 21 April 2023
  2. Cytokine Autoantibodies Are Associated with Infection Risk and Self-Perceived Health: Results from the Danish Blood Donor Study

    The presence of naturally occurring cytokine-specific autoantibodies (c-aAb) in humans is well established, as well as associations to selected...

    Jakob H. von Stemann, Ole B. Pedersen, ... Sisse R. Ostrowski in Journal of Clinical Immunology
    Article Open access 15 January 2020
  3. The Beneficial Clinical Effects of Teriflunomide in Experimental Autoimmune Myasthenia Gravis and the Investigation of the Possible Immunological Mechanisms

    Myasthenia gravis (MG) is an autoantibody-mediated autoimmune disease characterized by skeletal muscle weakness exacerbated with exercise. There is a...

    Emel Koseoglu, Neslihan Sungur, ... Ahmet Eken in Cellular and Molecular Neurobiology
    Article 11 October 2022
  4. Neuroimmune Mechanisms of Cerebellar Ataxias

    This chapter discusses cell- and autoantibody-mediated immune mechanisms impairing cerebellar neurons and circuits. Various autoimmune processes...
    Hiroshi Mitoma, Mario Manto in Essentials of Cerebellum and Cerebellar Disorders
    Chapter 2023
  5. COVID-19 and Autoimmunity

    Coronavirus disease 2019 (COVID-19), caused by the continuously evolving novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has been...
    Prashant S. Giri, Shahnawaz D. Jadeja, ... Mitesh Kumar Dwivedi in Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases
    Chapter 2022
  6. Enhancement of NETosis by ACE2-cross-reactive anti-SARS-CoV-2 RBD antibodies in patients with COVID-19

    Background

    High levels of neutrophil extracellular trap (NET) formation or NETosis and autoantibodies are related to poor prognosis and disease...

    Kun-Han Hsieh, Chiao-Hsuan Chao, ... Trai-Ming Yeh in Journal of Biomedical Science
    Article Open access 18 April 2024
  7. B cells in autoimmune hepatitis: bystanders or central players?

    B cells are central for the adaptive immune system to mount successful immune responses not only as antibody producers but also as regulators of...

    Christoph Schultheiß, Silja Steinmann, ... Mascha Binder in Seminars in Immunopathology
    Article Open access 29 April 2022
  8. Bispecific T cell engager therapy for refractory rheumatoid arthritis

    Bispecific T cell engagers (BiTEs) kill B cells by engaging T cells. BiTEs are highly effective in acute lymphoblastic leukemia. Here we treated six...

    Laura Bucci, Melanie Hagen, ... Ricardo Grieshaber-Bouyer in Nature Medicine
    Article 26 April 2024
  9. The Effect of Inhaled Air Particulate Matter SRM 1648a on the Development of Mild Collagen-Induced Arthritis in DBA/J Mice

    Air pollution is considered to be one of a risk factor for rheumatoid arthritis (RA). Collagen-induced arthritis (CIA) is commonly used as a mouse...

    Bernadeta Nowak, Grzegorz Majka, ... Janusz Marcinkiewicz in Archivum Immunologiae et Therapiae Experimentalis
    Article Open access 28 July 2022
  10. Extracellular Vesicle Biomarkers for Immune Disorders

    Abnormalities in the immune system can cause a range of autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis, and...
    Yiqin Ge, Yuji Huang, ... Li Li in Extracellular Vesicles
    Chapter 2024
  11. Mechanisms of Immunological Toxicity in Cancer Immunotherapy with Checkpoint Inhibitors

    The use of checkpoint inhibitors is revolutionizing the treatment outcomes in many cancer types. Besides this benefit, using checkpoint inhibitors...
    Polaczek Mateusz Marek, Rutkowski Piotr in Handbook of Cancer and Immunology
    Living reference work entry 2023
  12. Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity

    Glycoprotein 2 (GP2) is a widely distributed protein in the digestive tract, contributing to mucosal barrier maintenance, immune homeostasis, and...

    Zhongwei Zhang, Izumi Tanaka, ... Yosuke Kurashima in Seminars in Immunopathology
    Article Open access 03 January 2024
  13. Therapeutic potential of exosomes derived from mesenchymal stem cells for treatment of systemic lupus erythematosus

    Autoimmune diseases are caused by an imbalance in the immune system, producing autoantibodies that cause inflammation leading to tissue damage and...

    Shima Famil Samavati, Reza Yarani, ... Kamran Mansouri in Journal of Inflammation
    Article Open access 12 June 2024
  14. Anti-rheumatoid arthritis potential of Halodule pinifolia: development, characterization and in vivo evaluation of H. pinifolia-based oral suspension and lipid nano-emulsion

    For treating chronic diseases like rheumatoid arthritis, herbal medicines are preferred due to their evident therapeutic effects and lesser side...

    Samun Nessa, S. Lavanya, ... A. Sajeli Begum in Inflammopharmacology
    Article 07 March 2024
  15. Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus

    Systemic lupus erythematosus (SLE) is a life-threatening autoimmune disease characterized by adaptive immune system activation, formation of...

    Andreas Mackensen, Fabian Müller, ... Georg Schett in Nature Medicine
    Article 15 September 2022
  16. Immunopathogenesis of urticaria: a clinical perspective on histamine and cytokine involvement

    Background

    Urticaria is a clinical condition characterized by the appearance of wheals (hives), angioedema, or both. Over the last several decades, a...

    Rudranil Bhowmik, Md. Adil Shaharyar, ... Sanmoy Karmakar in Inflammation Research
    Article 31 March 2024
  17. Lymphocyte-Directed Immunomodulation Remits Thymoma-Associated Autoimmune Pneumonitis

    Background

    Thymoma presents with several autoimmune manifestations and is associated with secondary autoimmune regulator (AIRE) deficiency....

    Elise M. N. Ferré, Diana X. Nichols-Vinueza, ... Michail S. Lionakis in Journal of Clinical Immunology
    Article Open access 01 July 2024
  18. Anti-AQP4 autoantibodies promote ATP release from astrocytes and induce mechanical pain in rats

    Background

    Intractable neuropathic pain is a common symptom of neuromyelitis optica spectrum disorder (NMOSD). However, the underlying mechanism of...

    Teruyuki Ishikura, Makoto Kinoshita, ... Hideki Mochizuki in Journal of Neuroinflammation
    Article Open access 21 August 2021
  19. Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring Hospitalization

    Background and Purpose

    Waning immunity and the surge of SARS-CoV-2 variants are responsible for breakthrough infections, i.e., infections in fully...

    Giulia Lamacchia, Alessio Mazzoni, ... Francesco Annunziato in Journal of Clinical Immunology
    Article Open access 09 July 2022
  20. The potential roles of Th17 cells in the pathogenesis of oral lichen planus

    Background

    Oral lichen planus (OLP) is a T cell-mediated chronic autoimmune disease, whose pathogenesis and etiology are not entirely understood. OLP...

    Shima Afzali, Elham Mohammadisoleimani, ... Ali Moravej in Inflammation Research
    Article 06 July 2023
Did you find what you were looking for? Share feedback.